Düsseldorf/Amsterdam, 20 September 2022 – As of September 2022 Holland Capital is a full member of The German Private Equity and Venture Capital Association (BVK). With this membership, Holland Capital confirms its commitment to the German private equity market.
BVK: face and voice of the private equity industry
BVK is the face and voice of the private equity industry in Germany, they campaign for improvements to the fiscal environment and for easier access to private equity so that even more companies in Germany can benefit from private equity. BVK takes a stand on policy issues and the media in an effort to underline how important private equity is for the German economy. They observe the market and analyse its trends, as private equity can be a growth engine for innovation, start-ups and SME’s. www.bvkap.de/en
Holland Capital is committed to the German market
Ewout Prins, managing partner Holland Capital, “Holland Capital has been active for over 40 years as a private equity investor within the Healthcare and Technology sectors in the Dutch market. We see interesting opportunities in the German market for our investment strategy. To support the expansion of our activities into the German market, we opened our Düsseldorf office last year. We look forward to working with German entrepreneurs, investors and advisers. As such, we are pleased to have become member of the BVK. We shall be happy to contribute to the German Private Equity industry”.
About Holland Capital
Over the past 40 years, Holland Capital has responsibly and successfully invested in over more than 150 SME-companies. With a clear investment strategy Holland Capital is active in the attractive growth markets of Healthcare and Technology. Holland Capital’s experienced and committed investment team aims to establish an open, sustainable, and professional relationship with the companies they invest in, with the common goal of achieving growth. Holland Capital is backed by a broad network of successful entrepreneurs in the relevant growth markets and has her offices in Amsterdam (NL) and Düsseldorf (D).
Teledyne Dalsa has acquired the Sigmascreening B.V. patents
Amsterdam, 15 November 2022 – Teledyne DALSA, a Teledyne Technologies company and global leader in Digital X-Ray Image Sensing technology, is pleased to announce it has acquired the Sigmascreening B.V. patents and IP portfolio on pressure-sensitive breast compression...
AMP groep en 2MC bundelen krachten
Amsterdam/Houten, 14 november 2022 – Onze deelneming AMP Groep bundelt haar krachten met medisch logistiek bedrijf 2MC. Door de krachtenbundeling, die mede mogelijk wordt gemaakt door Holland Capital, breidt de organisatie haar positie in de medische logistieke...
Defibrion neemt DefibSolutions over en breidt haar activiteiten uit
Amsterdam, 1 november 2022 – Onze deelneming Defibrion neemt DefibSolutions over, een groothandel in AED’s en reanimatie artikelen. Met de krachtenbundeling versterkt Defibrion haar positie binnen de markt van AED’s en aanpalende producten en diensten op het gebied...
Channext haalt €4,5M Series A financiering op
Utrecht, 27 september 2022 - Partner marketing platform Channext haalt €4,5 miljoen financiering op. De Series A ronde wordt geleid door Holland Capital, die samen met het Graduate Entrepreneur Fund en huidige investeerders participeren. Met de investering wil...
Mauritskliniek sluit zich aan bij Corius
Amsterdam, 16 september 2022 – De Nederlandse Zorgautoriteit heeft haar goedkeuring gegeven aan de voorgenomen overname van onze deelneming Mauritskliniek door CORIUS. Mauritskliniek (incl. Kliniek Veldhoven) is een gerenommeerde keten focusklinieken op het gebied van...
Holland Capital investeert in ComplianceWise
Amsterdam, 6 september 2022 – Investeringsmaatschappij Holland Capital verstrekt groeifinanciering aan ComplianceWise, een SaaS-bedrijf dat oplossingen biedt aan financiële instellingen en dienstverleners, zoals accountants en belastingadviseurs. Deze partijen hebben...
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411
Düsseldorf
Köningsallee 42
40212 Düsseldorf
+49 (0) 211 96290120





